A Daraprim, Malocide, Pirimecidan, Pyrimethamine CEP of the European Pharmacopoeia monograph is often referred to as a Daraprim, Malocide, Pirimecidan, Pyrimethamine Certificate of Suitability (COS). The purpose of a Daraprim, Malocide, Pirimecidan, Pyrimethamine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Daraprim, Malocide, Pirimecidan, Pyrimethamine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Daraprim, Malocide, Pirimecidan, Pyrimethamine to their clients by showing that a Daraprim, Malocide, Pirimecidan, Pyrimethamine CEP has been issued for it. The manufacturer submits a Daraprim, Malocide, Pirimecidan, Pyrimethamine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Daraprim, Malocide, Pirimecidan, Pyrimethamine CEP holder for the record. Additionally, the data presented in the Daraprim, Malocide, Pirimecidan, Pyrimethamine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Daraprim, Malocide, Pirimecidan, Pyrimethamine DMF.
A Daraprim, Malocide, Pirimecidan, Pyrimethamine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Daraprim, Malocide, Pirimecidan, Pyrimethamine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Daraprim, Malocide, Pirimecidan, Pyrimethamine suppliers with CEP (COS) on PharmaCompass.